查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2150654

動靜脈移植市場報告：趨勢、預測與競爭分析（至2035年）

Arteriovenous Graft Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

動靜脈移植市場

受血液透析和外科手術市場機會的推動，全球動靜脈移植市場前景光明。預計2035年，全球動靜脈移植市場規模將從2027年的5.93億美元增加到9.02億美元，2027年至2035年的複合年成長率（CAGR）為8.6%。該市場的主要促進因素包括血液透析手術量的增加、人們對儘早獲得透析治療重要性的認知不斷提高，以及先進血管移植材料的廣泛應用。

  • 根據 Lucintel 的預測，由於合成接枝材料的可用性和耐用性，預計在預測期內合成接枝將呈現更高的成長率。
  • 從應用領域來看，由於需要終身血液透析的患者人數不斷增加，因此血液透析產業預計在整個預測期內將呈現更高的成長。
  • 從區域來看，亞太地區（APAC）預計將在預測期內呈現最高的成長率，這主要受慢性腎臟病率上升和透析中心數量增加的推動。

動靜脈移植市場的新趨勢

2025年至2027年間，動靜脈移植市場預計將從傳統血管移植物轉向更具抗感染性且能整合個別患者詳細資訊的新型移植物。末期腎功能衰竭（ESRD）和透析的整體發生率將推動末期腎功能衰竭市場的最大成長。 ESRD計畫的重點在於提高血管通路（VA）的有效性並最大限度地減少再次手術的次數。 Lucintel認為，患者特異性技術和在地化生產是關鍵的競爭因素。

  • 感染預防材料：抗菌和肝素塗層移植物表面的使用趨勢仍在持續。根據美國腎臟數據系統（USRDS）2024年的報告，末期腎病變（ESRD）病例總數預計將達到804,300例。鑑於ESRD病例的持續成長，血管通路裝置的使用壽命和住院次數將日益重要。因此，血管通路裝置製造商未來幾年可能會專注於生產更耐用的血管通路裝置。
  • 導管插入技術的改進：透析移植物的製造重點在於在指定的時間內提供血液透析通路。預計在2025年至2030年間，用於早期導管插入的移植物與修訂後的即時啟動透析方案相結合的方法將被廣泛接受。
  • 以患者為中心的個人化規劃：利用3D成像和電腦建模技術，可以根據解剖結構選擇合適的移植物。預計到2026年，20%的醫療機構會將影像技術納入血管通路規劃。透過提高移植物與患者血管系統的相容性，可以最大限度地減少血管扭曲和狹窄，並延長移植物使用壽命。
  • 製造：近年來，用於血管移植物紡織品的生產過程自動化程度提高，提高了產品的均勻性。此外，移植物最終檢驗的自動化也提高了血管移植物生產的一致性。預計2025年至2027年間，此類移植物產量將有所成長，有助於提高醫療系統的標準化程度和可近性。
  • 供應鏈：血管移植物製造商正努力減少對單一供應商在原料和滅菌製程方面的依賴。此外，預計2025年採購方式的變革將使醫院對植入患者體內的產品擁有更大的控制權。

未來幾年，製造商和醫療系統預計都會更加重視手術的臨床效果，而非手術數量。這將為血管移植物製造商創造機會，使其在市場競爭中脫穎而出。

動靜脈移植市場近期趨勢

從2025年到2027年，隨著透析中心對可靠血管通路的需求不斷成長，動靜脈移植市場預計將更加活躍。此外，移植片生產商正致力於研發抗感染型移植片。根據Lucintel預測，未來市場將更重視人工移植片的耐用性和血管通路的整體經濟效益。監管障礙的放寬也促進了血管移植片技術的進步，加快了核准流程。

  • 生物工程血管移植物核准：2024年12月，FDA核准了Humacyte公司生產的生物工程血管移植物Symvess（Humaair）首次用於人體。預計未來三到五年內，其他採用類似生物工程製程生產的血管移植物也將獲得批准。
  • 戈爾公司持續推動技術創新：戈爾公司的「Acuseal」平台憑藉其創新的抗感染移植物，已引起市場的廣泛關注。該平台目前正致力於開發可實現即時插管的血管通路移植物。
  • 透析產業重組：截至2025年2月，費森尤斯醫療報告稱，全球已有超過4,000家透析診所，顯示該產業正在經歷顯著的重組。透析設備的標準化有可能被少數幾家公司所主導。在這種情況下，大量採購將促使供應商提升設備效能，降低干預率，並努力實現更可靠的效能。
  • 臨床研究合作：由血管通路協會 (SVA) 贊助的幾項合作研究旨在評估血管通路相關結果（例如，患者層面的移植血管通暢率和血栓切除術），這些研究在 2025 年取得了進展。雖然過去外科醫師的偏好決定了透析通路的類型，但比較療效數據很可能成為決定是否在醫院處方清單中添加或刪除產品的主要因素。
  • 生產回流與供應鏈韌性：受新冠疫情期間全球供應鏈中斷的影響，醫療設備製造商重新評估了其供應鏈，並專注於使用來自一級和二級供應商的原料生產醫療設備。 2025年第一季，多家醫療設備製造商宣布對新建生產設施進行重大投資。這些新設施投入運作後，預計將縮短醫療設備的前置作業時間，並改善新興市場透析服務的可近性。

鑑於以上幾點，高耐用性血液透析通路裝置將成為未來幾年醫療設備製造商成長的主要驅動力。長期證據表明，此類裝置可減少與通路相關的干預措施，這將提升消費者對特定通路裝置的偏好。健保報銷機制和其他政策變化將要求醫療設備製造商降低與通路相關的治療成本，並改善通路相關的治療效果。

目錄

第1章執行摘要

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章：全球動靜脈移植市場：按類型分類

  • 吸引力分析：按類型
  • 合成接枝
  • 生物移植

第5章 全球動靜脈移植市場：依應用領域分類

  • 吸引力分析：依目的
  • 血液透析
  • 外科手術
  • 其他

第6章 區域分析

第7章：北美動靜脈移植市場

  • 北美動靜脈移植市場：按類型分類
  • 北美動靜脈移植市場：依應用領域分類
  • 美國動靜脈移植市場
  • 加拿大動靜脈移植市場
  • 墨西哥動靜脈移植市場

第8章：歐洲動靜脈移植市場

  • 歐洲動靜脈移植市場：按類型分類
  • 歐洲動靜脈移植市場：依應用領域分類
  • 德國動靜脈移植市場
  • 法國動靜脈移植市場
  • 義大利動靜脈移植市場
  • 西班牙動靜脈移植市場
  • 英國動靜脈移植市場

第9章：亞太地區動靜脈移植市場

  • 亞太地區動靜脈移植市場：依類型分類
  • 亞太地區動靜脈移植市場：依應用領域分類
  • 中國的動靜脈移植市場
  • 印度動靜脈移植市場
  • 日本動靜脈移植市場
  • 韓國動靜脈移植市場
  • 印尼動靜脈移植市場

第10章：世界其他地區動靜脈移植市場

  • 其他地區動靜脈移植市場：依類型分類
  • 其他地區的動靜脈移植市場：依應用領域分類
  • 中東動靜脈移植市場
  • 南美洲動靜脈移植市場
  • 非洲動靜脈移植市場

第11章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球動靜脈移植市場
  • 戰略分析

第13章：價值鏈中關鍵企業的公司概況

  • 競爭分析概述
  • Getinge Group
  • BD
  • Terumo
  • B.Braun
  • LeMaitre

第14章附錄

Arteriovenous Graft Market

The future of the global arteriovenous graft market looks promising with opportunities in the hemodialysis and surgical procedure markets. The global arteriovenous graft market is expected to reach an estimated $902 million by 2035 from $593 million in 2027 with a CAGR of 8.6% from 2027 to 2035. The major drivers for this market are the increase in hemodialysis procedure, the rising awareness regarding early dialysis access creation, and the growing adoption of advanced vascular graft materials.

  • Lucintel forecasts that, within the type category, synthetic grafts is expected to witness higher growth over the forecast period due to more availability and durability of synthetic graft materials.
  • Within the application category, hemodialysis is expected to witness higher growth over the forecast period due to increasing numbers of patients requiring lifelong hemodialysis.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increase of the incidence of chronic kidney disease as well as the number of dialysis centers.

Emerging Trends in Arteriovenous Graft Market

The arteriovenous graft market is expected to transition from traditional vascular conduits, and toward grafts which are resistant to infection and incorporation of individual patient's details, during the period of 2025-2027. The largest market opportunity will be created by the overall incidence of End-Stage Renal Disease (ESRD) and Dialysis. The focus of End-Stage Renal Disease Programs (ESRD Programs) is to improve the efficacy of Vascular Access (VA) and minimize the number of revisions. Lucintel predicts the key competition drivers will be patient-specific technologies and regional manufacturing.

  • Infection-resistant Materials: There is an ongoing trend towards utilizing antimicrobial and heparin-bonded graft surfaces. The 2024 USRDS report estimated that the overall incidence of ESRD was 804,300. Given the continual rise in ESRD, there will be an increasing emphasis on the duration of Access and the number of Hospitalizations. Therefore, it is probable that Access manufacturers will shift their focus toward the production of more durable Access devices in the ensuing years.
  • Improved Cannulation: The focus of the manufacture of dialysis grafts is to provide access for hemodialysis within a specified time period. The use of early-cannulation grafts in combination with a revised protocol for the immediate initiation of dialysis is likely to gain acceptance in the years 2025-2030.
  • Patient-specific Planning: The use of 3-D imaging and computer modelling is enabling anatomy-based graft selection. In 2026, 20% of centres are expected to include imaging in their plans for vascular access. Better alignment between the graft and the patient vasculature may minimize kinking and stenosis and could potentially extend the service life of the graft.
  • Manufacturing: Recent process automation in the production of textiles used in vascular grafts has allowed for improved uniformity. Further, the automation of a final inspection of the grafts have allowed for increased consistency in the production of vascular grafts. 2025-2027, anticipated increases in production of these grafts will allow for improved standardization and access within the health care system.
  • Supply Chain: Manufacturers of vascular grafts are making efforts to eliminate reliance on a single supplier for raw materials and sterilization. In addition, 2025 anticipated changes in procurement will allow hospitals to have greater control over the products implanted in patients.

In the coming years, there is expected to be a greater focus by both manufacturers and health care systems on the clinical outcomes of procedures, rather than the number of procedures performed. This should create opportunities for manufacturers of vascular grafts to differentiate themselves in the market.

Recent Developments in the Arteriovenous Graft Market

The arteriovenous graft market is expected to become more active from 2025-2027, as demand from dialysis facilities for reliable vascular access increases. Additionally, graft manufacturers focus on innovation to achieve grafts with infection-resistant properties. According to Lucintel, the future of the market will focus on the durability of engineered grafts and the overall economy of vascular access. Regulatory hurdles have eased, allowing advancements in vascular grafts to rapidly move through the approval process.

  • Approval of A Bioengineered Vascular Graft: In December 2024, the FDA approved the first human use of a bioengineered vascular graft, Symvess (Humaair), manufactured by Humacyte. It is expected that other vascular grafts manufactured through similar bioengineering processes will gain approval in the next 3 to 5 years.
  • Continued Advancements By Gore: The Acuseal platform of Gore gained significant attention in the market due to the innovative infection-resistant grafts. The platform further focuses on achieving vascular access grafts which allow for immediate cannulation.
  • Consolidation in The Dialysis Industry: With 4,000+ dialysis clinics reported by Fresenius Medical Care in February 2025, the consolidation in the industry is evident. There is a risk that the standardization of dialysis devices will be determined by a small number of companies. In such cases, centralized purchasing will lead suppliers to enhance the devices and strive for lower intervention rates and more dependable and reliable performance.
  • Partnerships for Clinical Research: Several collaborative studies, sponsored by the Society for Vascular Access (SVA), for evaluating vascular access-related outcomes (e.g. patient-level graft patency and thrombectomy) gained momentum in 2025. Unlike in the past, when a surgeon's preference determined the type of dialysis access, comparative effectiveness data will be the key driver for adding/removing a product from the hospital formulary.
  • Reshoring and Supply Chain Resiliency: Disruptions in the global supply chain during the COVID-19 pandemic prompted medical device manufacturers to re-evaluate their supply chains and focus on producing medical devices with raw materials from first and second tiers supplier. There were several public disclosures by device manufacturers during the first quarter of 2025 of significant investments for new manufacturing facilities. The new facilities, when operational, are expected to reduce the lead time for medical device availability and improve access to dialysis in emerging markets.

Considering the above, durable hemodialysis access will be the key driver of growth for medical device manufacturers in the coming years. Long-term evidence demonstrating a reduction in access-related interventions will drive preference for a particular access device. Reimbursement and other policy changes will require medical device manufacturers to lower the cost of access-related care and improve access-related outcomes.

Strategic Growth Opportunities in the Arteriovenous Graft Market

The dialysis population is growing, access failure is costly, and existing arteriovenous (AV) fistulas fail to meet the requirements for hemodialysis. Lucintel expects opportunities for device and access improvements from 2024 to 2026. Demand for improved vascular access will increase due to growing population needing renal replacement therapy.

  • Early Cannulation Grafts: With the U.S. renal replacement therapy population estimated to be over 800,000 (as of January 2025, per USRDS data), there is increasing demand to move patients to dialysis and eliminate their reliance on central venous catheters. Purchasing will favour products that shorten hospital stays and accelerate time to dialysis.
  • Infection-Resistant and Drug-Eluting Grafts: Antimicrobial and antithrombotic features, if effective in reducing thrombosis and access re-obstruction, can justify increased product cost. Bloodstream infections in the dialysis population, according to the June 2025 CDC report, remain of significant concern. Over the next several years, similar focus will be placed on reducing access related infections.
  • Ambulatory Dialysis Access Solutions: Beyond the cost of the graft, procedures to create vascular access are recurring revenue opportunities. Medicare estimates that in February 2025, it covered more than 7 million patients for end-stage renal disease. Manufacturers are investing in outpatient vascular access procedures and surgical centers, which are more profitable if located near a concentration of dialysis patients.
  • Emerging Markets: Suppliers can base their expansion in Latin America, the Middle East, and Southeast Asia on strategic alliances with dialysis service providers. In April 2025, Fresenius Medical Care had about 4,000 dialysis clinics. Graft manufacturers can be successful by focusing on high catheter dependence regions.
  • Individualized Graft Design: Image-based measurements can help address difficult anatomical situations. Manufacturers can improve the design of vascular access grafts by using 3D printing to prototype vascular accessories. Over the next few years, individualized design can help address vascular access in difficult situations.

Focusing on improving workflow, particularly in the areas of infection control and time to first cannulation, gives vascular graft manufacturers the opportunity to differentiate their products. Recent trends in the vascular graft industry suggest that in the coming years, manufacturers that build evidence-based clinical practices and services, and invest in regional service and support, will capture higher-margin markets. Purchasing teams at dialysis clinics will evaluate whole-treatment cost impact, and will consider graft price differently.

Arteriovenous Graft Market Drivers and Challenges

Advances in medical technology have resulted in greater options for treatment of end stage renal disease. However, several constraints, including risks associated with the use of medical devices, attitudes of the medical fraternity, and direct and indirect costs, have limited the widespread adoption of medical devices for vascular access.

The factors responsible for driving this market include:

  • Increase in The Number of Patients Suffering from End-stage Renal Disease: Rising levels of diabetes and hypertension, obesity, and aging have resulted in an increase in the number of patients requiring renal replacement therapy. As per the latest estimates available from the center for Medicare and Medicaid Services, the number of individuals in the US suffering from end stage renal disease was in excess of 800,000. With the expanding target population, there has been an increased emphasis on the creation of vascular access. A large portion of the patients are not ideal candidates for the creation of fistulas. In addition, vascular access may be required for plasmapheresis and chronic blood transfusions. With the increasing incidence and awareness of renal and other diseases, it is likely that the need for vascular access will also increase.
  • Technological Developments: Improvements in the manufacturing and surface coating of biomaterials reduce complications and enhance their functionality. In 2025, numerous ongoing studies of antimicrobial and other advanced vascular grafts technologies were being conducted. It is anticipated that with advanced biomaterials, therapies to treat vascular diseases would progressively become less invasive and improve recovery.
  • Investments in Health Care: The new facilities improved access to vascular surgery. Global investments in health care in 2025 exceeded $1 trillion, and new vascular access centres and dialysis facilities increased access to surgical care. New vascular surgery centres fostered competition, stimulated the development of new vascular access products, and enhanced global surgical teams. Initiatives to reduce the cost of hemodialysis, improve the accessibility of surgery, enhance graft quality and availability, especially in underserved areas, and foster regional and public-private partnerships would positively impact vascular health care.
  • Product Development: Factors such as flexibility, cannulation, and kinking have influenced the development of vascular grafts. Other considerations have included grafts' ability to conform to the body, and their overall size. As these factors continue to improve, the ability of grafts to support the body and maintain a patent lumen will also likely improve. Along with the ongoing advancement of prosthetics, increased collaboration between manufacturers and institutions will allow the development of specialized vascular grafts. This specialization, as well as the increased focus on patency, will give healthcare providers more options when treating vascular diseases and conditions.
  • Efficiency and Cost Effectiveness: There is a growing body of research and evidence that the development of better vascular grafts and the advancement of procedures to utilize them will lead to increased cost-effectiveness and improvements in healthcare. Research suggests that the greatest difference in cost will stem from a reduction in access revascularization procedures. Value-based health insurance reimbursement, and the increased focus of healthcare on reducing costs while improving quality, will reward the development of the best vascular grafts and related prosthetics.

The challenges facing this market include:

  • Infection and Thrombosis Risks: Thrombosis and infection are the most prevalent complications of AVGs. Stenosis and thrombosis lead to access failure and require repeated punctures. Complications of AVG increase the duration of hospital stays, increase the need for antibiotic therapy and surgery. The reviewed literature from 2025 reported infections between 5 to 20 percent. The presence of infection increases the risk of patient mortality. Over the next 3 to 5 years, it is expected that infection and thrombosis will continue to pose a major challenge to AVGs. To reduce these complications, the introduction of new technologies to improve surveillance and provide antimicrobial surfaces will be necessary. The preference for a vascular access method will be determined by the perceived complications.
  • Competition from AV Fistulas and Catheters: AV fistulas and catheters provide vascular access for hemodialysis. In 2025, AV fistulas accounted for more than 50 percent of all hemodialysis access in the U.S. Fistulas and catheters present a barrier for use of AVGs. The use of AVGs is restricted to patients who are unable to form AV fistulas and/or in patients who require immediate dialysis. In the next 3 to 5 years, ongoing improvement in fistula first strategies will continue to provide a barrier for AVGs. In order to increase use of AVGs, evidence to support its use in high risk patients will be needed.
  • Regulatory and Reimbursement Environment: Effective January 2026, new criteria require that all vascular grafts demonstrated improved safety, reduced infection, and improved clinical performance. The changes are expected to result in lengthier approval processes. Beyond these changes, manufacturers must contend with price ceilings and ongoing negotiations for reimbursement, constrained hospital budgets, and raw material costs. Supply and demand issues have affected the market, resulting in reduced adoption of new products. These conditions are expected to continue, and in the next three to five years, new regulatory requirements are expected to increase.

There are many positive factors influencing the arteriovenous gust market including the increase in the number of end stage renal disease patients requiring dialysis, as well as improved and innovative biomaterials. Improved and more accessible vascular access is likely to stimulate the market. Fistulas are preferred over synthetic vascular grafts; however, not all patients are eligible for fistulas. Also, vascular grafts are subject to infection and thrombosis. The market will experience the strongest growth in complex, high-skill access, and unmet clinical need.

List of Arteriovenous Graft Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies arteriovenous graft market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the arteriovenous graft market companies profiled in this report include-

  • Getinge Group
  • BD
  • Terumo
  • B.Braun
  • LeMaitre

Arteriovenous Graft Market by Segment

The study includes a forecast for the global arteriovenous graft market by type, application, and region.

Arteriovenous Graft Market by Type [Value ($M) from 2019 to 2035]:

  • Synthetic Grafts
  • Biological Grafts

Arteriovenous Graft Market by Application [Value ($M) from 2019 to 2035]:

  • Hemodialysis
  • Surgical Procedures
  • Others

Arteriovenous Graft Market by Region [Value ($M) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Arteriovenous Graft Market

From 2025 to 2027, the policy related to dialysis access, the state of domestic medical device manufacturing, and advances in vascular access technology will impact medical device procurement. Trends in supplier performance will be determined by the quality and availability of clinical data and the regulation of medical devices.

  • United States: From 2025 to 2027, changes in Medicare payment rates and the modernization of medical devices will occur. Hospital procurement of medical devices will depend on clinical evidence and the technology available to provide vascular access.
  • China: China is building its domestic supply of medical devices and reorganizing how it purchases medical devices at the provincial level. In 2025, China's Food and Drug Administration (FDA) opened more pathways to register medical devices at the national level. Meanwhile, provincial procurement programs developed more stringent procedures to evaluate price and weigh local supply. Lifetech Scientific and Jiangsu Yuyue deepened their local production of cardiovascular medical devices in 2025. Lifetech reported 40 product registrations in 2024 and plans to further increase local production and competition for foreign devices.
  • Germany: German medical device manufacturers concentrated on the forthcoming certification for market access under the EU Medical Device Regulation (MDR) and further customization of their medical device productions. Companies such as Aesculap, which manufactures surgical implants, continued serving hospitals in the EU. Aesculap reported global sales of 2.5 billion euros in 2024. Concentrated and customized production of grafts systems will influence the medical devices available in Germany and other EU countries.
  • India: The Indian government organizes large procurement processes and initiates local manufacturing in different sectors. The Indian Ministry of Health stated that in 2025, over 1.3 million dialysis sessions were performed by the Indian government. As a result, local device manufacturers increased their focus on vascular access manufacturing. Additionally, government procurement of dialysis grafts is likely to facilitate the use of locally manufactured grafts and reduce the dependence on foreign conducts in the future.
  • Japan: Access and Partnerships in Hospitals

The Japanese Society for Dialysis Therapy (JSDT) stated that in 2024, 340,000 patients in Japan underwent dialysis. Due to the large number of dialysis patients, Japanese hospitals and device manufacturers focused on improving and establishing durability of vascular access. Thus, improved vascular access grafts and sedentary dialysis remain in demand in Japan's dialysis market.

Features of the Global Arteriovenous Graft Market

  • Market Size Estimates: arteriovenous graft market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: arteriovenous graft market size by type, application, and region in terms of value ($B).
  • Regional Analysis: arteriovenous graft market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the arteriovenous graft market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the arteriovenous graft market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the arteriovenous graft market by type (synthetic grafts and biological grafts), application (hemodialysis, surgical procedures, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Arteriovenous Graft Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Synthetic Grafts : Trends and Forecast 2019 to 2035
  • 4.4 Biological Grafts : Trends and Forecast 2019 to 2035

5. Global Arteriovenous Graft Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hemodialysis : Trends and Forecast 2019 to 2035
  • 5.4 Surgical Procedures : Trends and Forecast 2019 to 2035
  • 5.5 Others : Trends and Forecast 2019 to 2035

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Arteriovenous Graft Market by Region

7. North American Arteriovenous Graft Market

  • 7.1 Overview
  • 7.2 North American Arteriovenous Graft Market by Type
  • 7.3 North American Arteriovenous Graft Market by Application
  • 7.4 The United States Arteriovenous Graft Market
  • 7.5 Canadian Arteriovenous Graft Market
  • 7.6 Mexican Arteriovenous Graft Market

8. European Arteriovenous Graft Market

  • 8.1 Overview
  • 8.2 European Arteriovenous Graft Market by Type
  • 8.3 European Arteriovenous Graft Market by Application
  • 8.4 German Arteriovenous Graft Market
  • 8.5 French Arteriovenous Graft Market
  • 8.6 Italian Arteriovenous Graft Market
  • 8.7 Spanish Arteriovenous Graft Market
  • 8.8 The United Kingdom Arteriovenous Graft Market

9. APAC Arteriovenous Graft Market

  • 9.1 Overview
  • 9.2 APAC Arteriovenous Graft Market by Type
  • 9.3 APAC Arteriovenous Graft Market by Application
  • 9.4 Chinese Arteriovenous Graft Market
  • 9.5 Indian Arteriovenous Graft Market
  • 9.6 Japanese Arteriovenous Graft Market
  • 9.7 South Korean Arteriovenous Graft Market
  • 9.8 Indonesian Arteriovenous Graft Market

10. ROW Arteriovenous Graft Market

  • 10.1 Overview
  • 10.2 ROW Arteriovenous Graft Market by Type
  • 10.3 ROW Arteriovenous Graft Market by Application
  • 10.4 Middle Eastern Arteriovenous Graft Market
  • 10.5 South American Arteriovenous Graft Market
  • 10.6 African Arteriovenous Graft Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global Arteriovenous Graft Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 Getinge Group
    • Company Overview
    • Arteriovenous Graft Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 BD
    • Company Overview
    • Arteriovenous Graft Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Terumo
    • Company Overview
    • Arteriovenous Graft Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 B.Braun
    • Company Overview
    • Arteriovenous Graft Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 LeMaitre
    • Company Overview
    • Arteriovenous Graft Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Arteriovenous Graft Market
  • Figure 2.1: Usage of Arteriovenous Graft Market
  • Figure 2.2: Classification of the Global Arteriovenous Graft Market
  • Figure 2.3: Supply Chain of the Global Arteriovenous Graft Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Arteriovenous Graft Market
  • Figure 4.1: Global Arteriovenous Graft Market by Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global Arteriovenous Graft Market ($B) by Type
  • Figure 4.3: Forecast for the Global Arteriovenous Graft Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Synthetic Grafts in the Global Arteriovenous Graft Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Biological Grafts in the Global Arteriovenous Graft Market (2019-2035)
  • Figure 5.1: Global Arteriovenous Graft Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global Arteriovenous Graft Market ($B) by Application
  • Figure 5.3: Forecast for the Global Arteriovenous Graft Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hemodialysis in the Global Arteriovenous Graft Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Surgical Procedures in the Global Arteriovenous Graft Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Others in the Global Arteriovenous Graft Market (2019-2035)
  • Figure 6.1: Trends of the Global Arteriovenous Graft Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global Arteriovenous Graft Market ($B) by Region (2027-2035)
  • Figure 7.1: Trends and Forecast for the North American Arteriovenous Graft Market (2019-2035)
  • Figure 7.2: North American Arteriovenous Graft Market by Type in 2019, 2026, and 2035
  • Figure 7.3: Trends of the North American Arteriovenous Graft Market ($B) by Type (2019-2026)
  • Figure 7.4: Forecast for the North American Arteriovenous Graft Market ($B) by Type (2027-2035)
  • Figure 7.5: North American Arteriovenous Graft Market by Application in 2019, 2026, and 2035
  • Figure 7.6: Trends of the North American Arteriovenous Graft Market ($B) by Application (2019-2026)
  • Figure 7.7: Forecast for the North American Arteriovenous Graft Market ($B) by Application (2027-2035)
  • Figure 7.8: Trends and Forecast for the United States Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European Arteriovenous Graft Market (2019-2035)
  • Figure 8.2: European Arteriovenous Graft Market by Type in 2019, 2026, and 2035
  • Figure 8.3: Trends of the European Arteriovenous Graft Market ($B) by Type (2019-2026)
  • Figure 8.4: Forecast for the European Arteriovenous Graft Market ($B) by Type (2027-2035)
  • Figure 8.5: European Arteriovenous Graft Market by Application in 2019, 2026, and 2035
  • Figure 8.6: Trends of the European Arteriovenous Graft Market ($B) by Application (2019-2026)
  • Figure 8.7: Forecast for the European Arteriovenous Graft Market ($B) by Application (2027-2035)
  • Figure 8.8: Trends and Forecast for the German Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC Arteriovenous Graft Market (2019-2035)
  • Figure 9.2: APAC Arteriovenous Graft Market by Type in 2019, 2026, and 2035
  • Figure 9.3: Trends of the APAC Arteriovenous Graft Market ($B) by Type (2019-2026)
  • Figure 9.4: Forecast for the APAC Arteriovenous Graft Market ($B) by Type (2027-2035)
  • Figure 9.5: APAC Arteriovenous Graft Market by Application in 2019, 2026, and 2035
  • Figure 9.6: Trends of the APAC Arteriovenous Graft Market ($B) by Application (2019-2026)
  • Figure 9.7: Forecast for the APAC Arteriovenous Graft Market ($B) by Application (2027-2035)
  • Figure 9.8: Trends and Forecast for the Japanese Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW Arteriovenous Graft Market (2019-2035)
  • Figure 10.2: ROW Arteriovenous Graft Market by Type in 2019, 2026, and 2035
  • Figure 10.3: Trends of the ROW Arteriovenous Graft Market ($B) by Type (2019-2026)
  • Figure 10.4: Forecast for the ROW Arteriovenous Graft Market ($B) by Type (2027-2035)
  • Figure 10.5: ROW Arteriovenous Graft Market by Application in 2019, 2026, and 2035
  • Figure 10.6: Trends of the ROW Arteriovenous Graft Market ($B) by Application (2019-2026)
  • Figure 10.7: Forecast for the ROW Arteriovenous Graft Market ($B) by Application (2027-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African Arteriovenous Graft Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Arteriovenous Graft Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Arteriovenous Graft Market (2026)
  • Figure 12.1: Growth Opportunities for the Global Arteriovenous Graft Market by Type
  • Figure 12.2: Growth Opportunities for the Global Arteriovenous Graft Market by Application
  • Figure 12.3: Growth Opportunities for the Global Arteriovenous Graft Market by Region
  • Figure 12.4: Emerging Trends in the Global Arteriovenous Graft Market

List of Tables

  • Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Arteriovenous Graft Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Arteriovenous Graft Market by Region
  • Table 1.3: Global Arteriovenous Graft Market Parameters and Attributes
  • Table 3.1: Trends of the Global Arteriovenous Graft Market (2019-2026)
  • Table 3.2: Forecast for the Global Arteriovenous Graft Market (2027-2035)
  • Table 4.1: Attractiveness Analysis for the Global Arteriovenous Graft Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Arteriovenous Graft Market (2019-2026)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Arteriovenous Graft Market (2027-2035)
  • Table 4.4: Trends of Synthetic Grafts in the Global Arteriovenous Graft Market (2019-2026)
  • Table 4.5: Forecast for Synthetic Grafts in the Global Arteriovenous Graft Market (2027-2035)
  • Table 4.6: Trends of Biological Grafts in the Global Arteriovenous Graft Market (2019-2026)
  • Table 4.7: Forecast for Biological Grafts in the Global Arteriovenous Graft Market (2027-2035)
  • Table 5.1: Attractiveness Analysis for the Global Arteriovenous Graft Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Arteriovenous Graft Market (2019-2026)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Arteriovenous Graft Market (2027-2035)
  • Table 5.4: Trends of Hemodialysis in the Global Arteriovenous Graft Market (2019-2026)
  • Table 5.5: Forecast for Hemodialysis in the Global Arteriovenous Graft Market (2027-2035)
  • Table 5.6: Trends of Surgical Procedures in the Global Arteriovenous Graft Market (2019-2026)
  • Table 5.7: Forecast for Surgical Procedures in the Global Arteriovenous Graft Market (2027-2035)
  • Table 5.8: Trends of Others in the Global Arteriovenous Graft Market (2019-2026)
  • Table 5.9: Forecast for Others in the Global Arteriovenous Graft Market (2027-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Arteriovenous Graft Market (2019-2026)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Arteriovenous Graft Market (2027-2035)
  • Table 7.1: Trends of the North American Arteriovenous Graft Market (2019-2026)
  • Table 7.2: Forecast for the North American Arteriovenous Graft Market (2027-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Arteriovenous Graft Market (2019-2026)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Arteriovenous Graft Market (2027-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Arteriovenous Graft Market (2019-2026)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Arteriovenous Graft Market (2027-2035)
  • Table 7.7: Trends and Forecast for the United States Arteriovenous Graft Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Arteriovenous Graft Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Arteriovenous Graft Market (2019-2035)
  • Table 8.1: Trends of the European Arteriovenous Graft Market (2019-2026)
  • Table 8.2: Forecast for the European Arteriovenous Graft Market (2027-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Arteriovenous Graft Market (2019-2026)
  • Table 8.4: Market Size and CAGR of Various Type in the European Arteriovenous Graft Market (2027-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Arteriovenous Graft Market (2019-2026)
  • Table 8.6: Market Size and CAGR of Various Application in the European Arteriovenous Graft Market (2027-2035)
  • Table 8.7: Trends and Forecast for the German Arteriovenous Graft Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Arteriovenous Graft Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Arteriovenous Graft Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Arteriovenous Graft Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Arteriovenous Graft Market (2019-2035)
  • Table 9.1: Trends of the APAC Arteriovenous Graft Market (2019-2026)
  • Table 9.2: Forecast for the APAC Arteriovenous Graft Market (2027-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Arteriovenous Graft Market (2019-2026)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Arteriovenous Graft Market (2027-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Arteriovenous Graft Market (2019-2026)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Arteriovenous Graft Market (2027-2035)
  • Table 9.7: Trends and Forecast for the Japanese Arteriovenous Graft Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Arteriovenous Graft Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Arteriovenous Graft Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Arteriovenous Graft Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Arteriovenous Graft Market (2019-2035)
  • Table 10.1: Trends of the ROW Arteriovenous Graft Market (2019-2026)
  • Table 10.2: Forecast for the ROW Arteriovenous Graft Market (2027-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Arteriovenous Graft Market (2019-2026)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Arteriovenous Graft Market (2027-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Arteriovenous Graft Market (2019-2026)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Arteriovenous Graft Market (2027-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Arteriovenous Graft Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Arteriovenous Graft Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Arteriovenous Graft Market (2019-2035)
  • Table 11.1: Product Mapping of Arteriovenous Graft Suppliers Based on Segments
  • Table 11.2: Operational Integration of Arteriovenous Graft Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Arteriovenous Graft Revenue
  • Table 12.1: New Product Launches by Major Arteriovenous Graft Producers (2019-2026)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Arteriovenous Graft Market